Residual leukaemia after bone marrow transplant in children with acute lymphoblastic leukaemia after first haematological relapse or with poor initial presenting features-Reference-Cited by-同舟云学术

Residual leukaemia after bone marrow transplant in children with acute lymphoblastic leukaemia after first haematological relapse or with poor initial presenting features

Published:2003-02 Issue:4 Volume:120 Page:711-715
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:

Author:

Bunin Nancy,Johnston Dennis A.,Roberts W. Mark,Ouspenskaia Maia V.,Papusha Victor Z.,Brandt Mark A.,Zipf Theodore F.

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1365-2141.2003.04135.x/fullpdf

Reference19 articles.

1. Bone marrow transplantation for acute lymphoblastic leukaemia;Barrett;Baillieres Clinical Haematology,1994

2. Bone marrow transplants from HLA-identical siblings as compared with chemotherapy for children with acute lymphoblastic leukemia in a second remission;Barrett;New England Journal of Medicine,1994

3. Improved assessment of minimal residual disease in B-cell malignancies using fluorogenic consensus probes for real-time quantitative PCR;Bruggemann;Leukemia,2000

4. Quantification of minimal residual disease in T-lineage acute lymphoblastic leukemia with the TAL-1 deletion using a standardized real-time PCR assay;Chen;Leukemia,2001

5. Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation;Collins;Journal of Clinical Oncology,1997

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Redefining treatment failure for pediatric acute leukemia in the era of minimal residual disease testing;Pediatric Hematology and Oncology;2017-10-03

2. Monitoring of Minimal Residual Disease After Allogeneic Stem-Cell Transplantation in Relapsed Childhood Acute Lymphoblastic Leukemia Allows for the Identification of Impending Relapse: Results of the ALL-BFM-SCT 2003 Trial;Journal of Clinical Oncology;2015-04-10

3. Minimal residual disease in acute lymphoblastic leukemia: optimal methods and clinical relevance, pitfalls and recent approaches;Medical Oncology;2014-10-07

4. Immunoglobulin and T Cell Receptor Gene High-Throughput Sequencing Quantifies Minimal Residual Disease in Acute Lymphoblastic Leukemia and Predicts Post-Transplantation Relapse and Survival;Biology of Blood and Marrow Transplantation;2014-09

5. Impact of Minimal Residual Disease, Detected by Flow Cytometry, on Outcome of Myeloablative Hematopoietic Cell Transplantation for Acute Lymphoblastic Leukemia;Leukemia Research and Treatment;2014-03-23